274 related articles for article (PubMed ID: 10335865)
21. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
[TBL] [Abstract][Full Text] [Related]
22. Evidence of ongoing replication in a human immunodeficiency virus type 1 persistently infected cell line.
Olivares I; Sánchez-Jiménez C; Vieira CR; Toledano V; Gutiérrez-Rivas M; López-Galíndez C
J Gen Virol; 2013 May; 94(Pt 5):944-954. PubMed ID: 23288426
[TBL] [Abstract][Full Text] [Related]
23. Quantification of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of antiretroviral therapy.
Furtado MR; Murphy R; Wolinsky SM
J Infect Dis; 1993 Jan; 167(1):213-6. PubMed ID: 8418170
[TBL] [Abstract][Full Text] [Related]
24. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
[TBL] [Abstract][Full Text] [Related]
25. Unintegrated viral DNA as a marker for human immunodeficiency virus 1 infection in vivo and in vitro.
Nandi JS
Acta Virol; 1999 Dec; 43(6):367-72. PubMed ID: 10825926
[TBL] [Abstract][Full Text] [Related]
26. Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates.
Boucher CA; van Leeuwen R; Kellam P; Schipper P; Tijnagel J; Lange JM; Larder BA
Antimicrob Agents Chemother; 1993 Jul; 37(7):1525-30. PubMed ID: 8103317
[TBL] [Abstract][Full Text] [Related]
27. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.
Gervaix A; West D; Leoni LM; Richman DD; Wong-Staal F; Corbeil J
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4653-8. PubMed ID: 9114046
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
[TBL] [Abstract][Full Text] [Related]
29. [Chronically HIV-1 infected human monocyte culture U937 as a model for assessing the efficacy of anti-HIV agents].
Pokrovskiĭ AG; Pliasunova OA; Gashnikova NM; Mamaeva OA; Fediuk NV
Vopr Virusol; 2001; 46(6):38-42. PubMed ID: 11785387
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
[TBL] [Abstract][Full Text] [Related]
31. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS.
Teo I; Veryard C; Barnes H; An SF; Jones M; Lantos PL; Luthert P; Shaunak S
J Virol; 1997 Apr; 71(4):2928-33. PubMed ID: 9060651
[TBL] [Abstract][Full Text] [Related]
32. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
[TBL] [Abstract][Full Text] [Related]
33. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
34. Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
Panther LA; Coombs RW; Zeh JE; Collier AC; Corey L
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):303-13. PubMed ID: 9525430
[TBL] [Abstract][Full Text] [Related]
35. Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models.
Bonczkowski P; De Scheerder MA; Malatinkova E; Borch A; Melkova Z; Koenig R; De Spiegelaere W; Vandekerckhove L
Sci Rep; 2016 Dec; 6():38329. PubMed ID: 27910923
[TBL] [Abstract][Full Text] [Related]
36. Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
Connell EV; Hsu MC; Richman DD
Antimicrob Agents Chemother; 1994 Feb; 38(2):348-52. PubMed ID: 7514858
[TBL] [Abstract][Full Text] [Related]
37. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
Kaye S; Comber E; Tenant-Flowers M; Loveday C
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species.
Baba M; Okamoto M; Takeuchi H
Antimicrob Agents Chemother; 1999 Oct; 43(10):2350-5. PubMed ID: 10508005
[TBL] [Abstract][Full Text] [Related]
39. Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.
Perez-Bercoff D; David A; Sudry H; Barré-Sinoussi F; Pancino G
J Virol; 2003 Apr; 77(7):4081-94. PubMed ID: 12634367
[TBL] [Abstract][Full Text] [Related]
40. A quantitative assay for HIV DNA integration in vivo.
Butler SL; Hansen MS; Bushman FD
Nat Med; 2001 May; 7(5):631-4. PubMed ID: 11329067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
